Association of Immunology and Rheumatology Middle East Rheumatology Conference 2025

50 $

+ Include: 47 videos + 47 file sub vtt + 47 pdfs, size: 14.07 GB

+ Target Audience: rheumatologists, immunologists, and internists

Description

+ Include: 47 videos + 47 file sub vtt + 47 pdfs, size: 14.07 GB

+ Target Audience: rheumatologists, immunologists, and internists

+ Sample video: contact me for sample video

+ Information:

1. Overview

The highly anticipated three-day event united top regional and international experts to focus on the latest scientific breakthroughs, diagnostic challenges, and practical treatment strategies in rheumatology and allied specialties.

The Middle East Rheumatology Conference (MRC) 2025 was a key event for scientific exchange in the field of rheumatology. Organized by a dedicated team of experts, it provided a platform for advancing knowledge, fostering collaboration, and discussing the latest research and innovations. Through its educational initiatives, MRC strengthened the regional medical community and enhanced patient care.

Course Date: May 16–18, 2025 at Sofitel Dubai The Obelisk in Dubai, UAE

Key Highlights from MRC 2025:
  • Clinical Excellence: Features included dynamic case-based interactive discussions, keynote lectures, and practical workshops.
  • Core Topics: Sessions explored critical subjects such as diagnostic challenges in autoinflammatory diseases, malignancy in autoimmune diseases, and managing complex cases of difficult-to-treat uveitis.
  • Specialized Tracks: The event included a dedicated pediatric rheumatology program alongside focused talks on precision medicine and immunology.

2. Learning Objectives

  • Evaluate the clinical application of B-cell targeted therapies, CAR T-cells, and checkpoint inhibitors in autoimmune diseases like SLE.

  • Formulate precision medicine strategies for managing psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis based on patient profiling.

  • Navigate challenging clinical cases, including difficult-to-treat uveitis, infective spondylitis, and malignancies associated with autoimmune diseases.

  • Implement multidisciplinary management approaches for complex conditions such as Lupus Nephritis, CNS Vasculitis, and VEXAS syndrome.

  • Assess the rheumatologic impact of emerging global health issues, including Post-COVID autoimmune manifestations and immune therapy in oncology patients.

3. Target Audience

Best for rheumatologists, immunologists, and internists who want updates on precision medicine, targeted therapies, and complex autoimmune cases.

4. Topics

  1. Anti-MDA5 Positive JDM

  2. Basic Science B-cell Targeted Therapy in SLE From monoclonal antibodies to CAR T cell

  3. Basic Science Check Point Inhibitors and Autoimmunity

  4. Basic Science IBD and Spodyloarthropathy Arthropathy

  5. Basic Science Macrophage Activation Syndrome

  6. Basic Science Precision Medicine in Psoriatic Arthritis and its Clinical Application

  7. Bone Health in Children on Glucorticoids

  8. Case Based Discussion Familial Mediterranean Fever

  9. Case Based Discussoin – Radiology cases

  10. Case Based Interactive Discussion Difficult to Treat Uveitis

  11. Case Based Interactive Discussion Infective Spondylitis

  12. Case Based Interactive Discussion Malignancy in Autoimmune Diseases

  13. Case Based Interactive Discussion Precision medicine in Ankylosing spondylitis- How it helps making treatment decisions

  14. Challenging Case 1

  15. Challenging Case 2

  16. Challenging Case 3

  17. Challenging Case 4

  18. CNS Vasculitis

  19. Dermatological Manifestations of RMDs

  20. Developing a World Class AxSpA Service

  21. Glucocorticoid-Induced Osteoporosis

  22. Hematological Mimickers of Rheumatologic Diseases

  23. JDM Associated ILD Pulmonologist’s perspective

  24. Keynote – Main Hall – DAY 2

  25. Keynote 1 – Hall B – DAY 2

  26. Keynote 2 – Hall B – DAY 2

  27. Keynote Management of catastrophic APS- what’s new

  28. Keynote Precision Medicine in Rheumatoid Arthritis and Patient Profiling

  29. Keynote Skin in Rheumatic Diseases- When to refer to rheumatologist

  30. Keynote VEXAS syndrome

  31. IgG4-related Disease What’s New

  32. Local Experience AS Guidelines

  33. Local Experience Interstitial Lung disease in CTDs- How are we doing

  34. Local Experience KDIGO Lupus Nephritis Guidelines

  35. Local Experience Post-COVID autoimmune diseases

  36. Local Experience Rheumatic Aspect of Immune Therapy in Oncology Patients

  37. Lupus Nephritis A Rheumatology Perspective

  38. Lupus Nephritis Nephrologist’s perspective

  39. Noninflammatory Causes of Joint Pain

  40. Refractory Myositis

  41. Rheumatic Manifestations GI Diseases

  42. Septic Arthritis What’s New

  43. Updates in Kawasaki Disease A Cardiologists Perspective

  44. Uveitis Ophthalmologist’s perspective

  45. Uveitis Rheumatologist’s perspective

  46. What’s new in Autoinflammatory Diseases

  47. What’s new in CNO

Reviews

There are no reviews yet.

Be the first to review “Association of Immunology and Rheumatology Middle East Rheumatology Conference 2025”

Your email address will not be published. Required fields are marked *

9 + 1 =
Powered by MathCaptcha